ArticleMycopathologia2025
Aspartic Proteases Drive Stress Response, Morphogenesis, and Macrophage Interaction in Sporothrix brasiliensis.
Article in Mycopathologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Sporotrichosis, a globally distributed subcutaneous mycosis, finds its most virulent agent in the species Sporothrix brasiliensis, particularly in zoonotic outbreaks associated with cats. This study investigated the role of aspartic proteases (APs) as potential virulence factors in S. brasiliensis. Through in silico analysis, we identified and characterized 19 genes encoding putative aspartic proteases in the S. brasiliensis genome. Susceptibility assays to different stressors demonstrated distinct profiles between the Sb1168 and Sb5110 strains, but the presence of Pepstatin A strongly inhibited growth under stress, indicating a crucial role for these enzymes in environmental adaptation. Proteolytic activity was modulated by cell wall stressors. Strain Sb1168 showed higher aspartic protease activity (87% inhibition by pepstatin A), while Sb5110 exhibited a mixed enzymatic profile, with significant contributions from metalloproteases (50% inhibition by EDTA and pepstatin A individually, and 80% in combination). Inhibition of APs blocked the mycelium-to-yeast (M → Y) dimorphic transition, suggesting that these proteases are dimorphism regulators. In macrophage assays, APs inhibition resulted in a significant increase in the phagocytic index and a reduction in intracellular fungal viability (CFU count), in addition to altering the profile of secreted cytokines (increase in pro-inflammatory IL-12 and decrease in anti-inflammatory IL-10 in treated Sb1168), suggesting these enzymes modulate immune evasion.
Indexed as
Identifiers
41402656What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.